Tumor thickness influences prognosis of T1 and T2 oral cavity cancer—but what thickness?
- 12 June 2003
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 25 (11) , 937-945
- https://doi.org/10.1002/hed.10324
Abstract
Background. Previous studies have demonstrated that tumor thickness might influence prognosis in oral cancer, but the significant point at which outcome changes has varied from 1.5 mm to 6 mm. The clinical relevance of thickness remains unclear, and a reproducible prognostic “breakpoint” needs to be defined. Methods. Tumor thickness was measured in 145 oral cavity squamous cancers, clinically staged T1 (n = 62) or T2 (n = 83). Clinical and pathologic data were collected prospectively between 1988 and 2000, but thickness was measured on paraffin sections for this study. Minimum follow-up was 2 years, and thickness was correlated with local control, cervical node involvement, and survival. Patients with clinically positive nodes (n = 21) were not excluded. Overall, 55 patients had pathologic node involvement at some time in their disease. Results. Median tumor thickness was 6.2 mm, and there was little variation between sites: tongue, 6.4 mm; floor of mouth, 6.6 mm; and other sites, 5.7 mm. Median thickness for T1 tumors was 4.3 mm, significantly less than the T2 group, 8 mm (p < .01). Median thickness also varied significantly for tumors with associated nodal disease (8.5 mm) and without nodal disease (5.8 mm) (p < .01). Prognosis changed significantly at a cutoff of 4 mm with local control, nodal disease, and survival rates of 91%, 8%, and 100%, respectively, for tumors p < .01). Subgrouping greater than and less than 3 mm and 5 mm also showed a difference but with poorer discrimination. Thickness and pathologic nodal involvement were highly significant independent prognostic factors. Conclusions. Tumor thickness is a highly significant, objectively measurable prognostic factor in early stage oral cancers. There is a need to standardize techniques of measurement to allow a multiinstitutional study to be carried out. This will facilitate the development of strategies aimed at improving the outcome of higher risk patients. © 2003 Wiley Periodicals, Inc. Head Neck 25: 000–000, 2003Keywords
This publication has 19 references indexed in Scilit:
- Prognostic factors of clinically stage I and II oral tongue carcinoma—A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, martinez‐gimeno score, and pathologic featuresHead & Neck, 2002
- Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavityHead & Neck, 2002
- Surgical treatment of early oral carcinoma—Results of a prospective controlled multicenter studyHead & Neck, 2001
- The Use of Clinical Criteria Alone in the Management of the Clinically Negative Neck Among Patients With Squamous Cell Carcinoma of the Oral Cavity and OropharynxJAMA Otolaryngology–Head & Neck Surgery, 2000
- Pattern of invasion and margin assessment in patients with oral tongue cancerHead & Neck, 1999
- T1 and T2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissectionHead & Neck, 1999
- Resection Margin as a Predictor of Recurrence at the Primary Site for T1 and T2 Oral Cancers: Evaluation of Histopathologic VariablesJAMA Otolaryngology–Head & Neck Surgery, 1996
- Treatment of stage I and II oral tongue cancerHead & Neck, 1993
- Brachytherapy for stage I & II oral tongue cancer: An analysis of past cases focusing on control and complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prognostic Factors in the Recurrence of Stage I and II Squamous Cell Cancer of the Oral CavityJAMA Otolaryngology–Head & Neck Surgery, 1992